• Canadian Critical Care Trials Group
    The Canadian Critical Care Trials Group (CCCTG) is a highly collegial group that is dedicated to the pursuit of excellence and advancement of critical care research in Canada.
  • Canadian Critical Care Trials Group
    The CCCTG has are more than 30 research programs underway and over 100 peer-reviewed publications to its credit, with direct impact on clinical practice in critical care.
  • Canadian Critical Care Trials Group
    The Canadian Critical Care Trials Group (CCCTG) is a national organization of more than 300 individuals with research interests in the management of the critically ill patient.
  • Canadian Critical Care Trials Group
    Endorsement by the CCCTG communicates our full commitment to ensure that the work is undertaken in a rigorous and ethical manner, and communicated in a timely and effective way.
Members

Institution

Foothills Medical Centre

City

Calgary

Contact This Member

Henry T. Stelfox

Dr. Tom Stelfox is Professor and Department Head of Critical Care Medicine at the University of Calgary and Alberta Health Services- Calgary Zone. He received his M.D. from the University of Alberta, Internal Medicine Residency at the University of Toronto, Ph.D. in Health Care Policy at Harvard University and Critical Care Fellowship at the Massachusetts General Hospital.  His research program focuses on the application of health services research methods to evaluate and improve the quality of health care delivery to critically ill patients.  His research activities include developing quality indicators; developing strategies to improve continuity of patient care across the care continuum; and improving the translation of scientific evidence into clinical practice. He has more than 250 peer-reviewed publications with 10,000+ citations and has received more than $16 million in funding as principal investigator and more than $55 million in network and training grants as co-investigator. The findings from his work have impacted health policy and patient care.